Saroja Pharma Industries India Past Earnings Performance
Past criteria checks 2/6
Saroja Pharma Industries India has been growing earnings at an average annual rate of 11.8%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been declining at an average rate of 14.5% per year. Saroja Pharma Industries India's return on equity is 4.8%, and it has net margins of 1.9%.
Key information
11.8%
Earnings growth rate
-40.7%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -14.5% |
| Return on equity | 4.8% |
| Net Margin | 1.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Saroja Pharma Industries India makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 383 | 7 | 15 | 0 |
| 30 Jun 24 | 395 | 8 | 16 | 0 |
| 31 Mar 24 | 407 | 9 | 16 | 0 |
| 31 Dec 23 | 427 | 9 | 16 | 0 |
| 30 Sep 23 | 448 | 10 | 16 | 0 |
| 30 Jun 23 | 475 | 10 | 16 | 0 |
| 31 Mar 23 | 502 | 11 | 16 | 0 |
| 31 Mar 22 | 556 | 11 | 13 | 0 |
| 31 Mar 21 | 367 | 7 | 10 | 0 |
| 31 Mar 20 | 171 | 2 | 8 | 0 |
Quality Earnings: SAROJA has high quality earnings.
Growing Profit Margin: SAROJA's current net profit margins (1.9%) are lower than last year (2.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SAROJA's earnings have grown by 11.8% per year over the past 5 years.
Accelerating Growth: SAROJA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SAROJA had negative earnings growth (-29.8%) over the past year, making it difficult to compare to the Healthcare industry average (33.2%).
Return on Equity
High ROE: SAROJA's Return on Equity (4.8%) is considered low.